HOSPIRA, INC. for HOSPIRA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Mid-Year Report (this page) | Aug 13, 2007 | $40,000 | Replaced |
| Mid-Year Report | Aug 13, 2007 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 1038 / S 623: "Access to Life Saving Medicines Act", Support Biogenerics. In the Senate: "The Biologics Price Competition and Innovation Act of 2007", Supports Biogenerics. S 1082: "The FDA Revitalization Act of 2007", Reauthorizes prescription drug and medical device user fee legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.